Skip to main content
. 2017 Apr 1;19(4):255–264. doi: 10.1089/dia.2016.0405

Table 3.

Glycemic Fluctuation and Variability in Patients with Type 2 Diabetes Treated for 52 Weeks in the DUAL I Extension Continuous Glucose Monitoring Sub-Study

CGM parameter IDegLira (n = 131) IDeg (n = 64) ETD [95% CI]: IDegLira vs. IDeg Lira (n = 65) ETD [95% CI]: IDegLira vs. Lira
Mean IG (mmol/L)
 Mean at baseline 10.2 (2.2) 10.2 (2.1)   10.0 (2.5)  
 Mean Δ, w52 −3.5 (1.9) −3.6 (1.9) 0.0 [−0.5 to 0.5] (P = 0.9655) −2.5 (2.5) −1.0 [−1.5 to −0.5] (P < 0.0001)
IG fluctuation (adjusted integrated absolute distance from the mean profile, i.e., flatness of IG profile, mmol/L)
 Geometric mean at baseline 1.5 1.6   1.5  
 Geometric mean at w52 1.0 1.3 Ratio: 0.8 [0.7 to 0.9] (P = 0.0018) 1.1 Ratio: 1.0 [0.8 to 1.1] (P = 0.6681)
Postprandial IG increment across all meals (90 min, mmol/L)
 Mean at baseline 1.4 (1.3) 1.4 (1.8)   1.5 (1.2)  
 Mean Δ, w52 −0.5 (1.2) 0.2 (1.8) −0.5 [−0.9 to −0.1] (P = 0.0288) −0.2 (1.4) −0.2 [−0.6 to 0.2] (P = 0.3039)
Day-to-day IG variability (SD of daily [24 h] mean, mmol/L)
 Mean at baseline (SE) 0.8 (0.1) 1.0 (0.1)   0.8 (0.1)  
 Mean at w52 (SE) 0.6 (0.0) 0.6 (0.1) −0.1 [−0.2 to 0.1] (P = 0.4197) 0.5 (0.1) 0.1 [−0.0 to 0.3] (P = 0.1056)
Day-to-day variability of fasting IG, 20 min before breakfast (SD of daily fasting IG, mmol/L)
 Geometric mean at baseline (CV) 0.8 (115.4) 0.7 (130.4)   0.8 (127.5)  
 Geometric mean at w52 (CV) 0.6 (106.7) 0.5 (139.9) Ratio: 0.9 [0.6 to 1.3] (P = 0.4811) 0.5 (121.1) Ratio: 0.8 [0.5 to 1.2] (P = 0.2462)

Values are mean (SD) unless otherwise stated. CGM parameters are analyzed based on observed data using an ANCOVA method with treatment, region, baseline HbA1c stratum (≤8.3% [≤67 mmol/mol], >8.3% [>67 mmol/mol]), and previous OAD treatment as fixed effects. Baseline values of parameters were included as covariates for mean IG and postprandial IG increment. Fluctuation is log-transformed before analysis.

ANCOVA, analysis of covariance; CV, coefficient of variation; ETD, estimated treatment difference; IG, interstitial glucose; Lira, liraglutide; SE, standard error; w, week.